Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda

Tropical Medicine and International Health

Volumn 6, Issue 5, 2001, Pages 407-411

  Matovu, E ^a,b,c,d   Enyaru, J C K ^a,b,c,d   Legros, D ^a,b,c,d   Schmid, C ^a,b,c,d   Seebeck, T ^a,b,c,d   Kaminsky, R ^a,b,c,d,e  

^a Livestock Health Research Institute Uganda   (Uganda)

^b Swiss Tropical Institute ^*

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d Institute of Cell Biology   (Switzerland)

^e Centre de Recherche Santé Animale   (Switzerland)

Author keywords

Melarsoprol; Relapse; Sleeping sickness; T. b. gambiense; Uganda

Indexed keywords

ADENOSINE; ARSENIC; CARRIER PROTEIN; EFLORNITHINE; MELARSOPROL;

AFRICAN TRYPANOSOMIASIS; ANTIBIOTIC RESISTANCE; ARTICLE; COTE D'IVOIRE; GEOGRAPHIC DISTRIBUTION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; RECURRENT DISEASE; TRYPANOSOMA GAMBIENSE; TRYPANOSOMA RHODESIENSE; UGANDA;

PROTOZOA; TRYPANOSOMA; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMA BRUCEI RHODESIENSE;

EID: 0034985389     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2001.00712.x     Document Type: Article

References (14)

1. Pharmacokinetic properties of the trypanocidal drug melarsoprol
2. Arsenical resistant trypanosomes lack an unusual adenosine transporter
3. Role of antibody in elimination of trypanosomes after DL-α-difluoromethylornithine chemotherapy
4. Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-difluoromethylornithine (DFMO)
5. Trypanosoma brucei brucei: Expression of drug resistance in vitro
6. Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose
7. Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda
8. Identification of three ABC transporter genes in Trypanosoma brucei ssp.
9. A nucleoside transporter from Trypanosoma brucei involved in drug resistance
10. Susceptibility of Ugandan Trypanosoma brucei rhodesiense isolated from man and animal reservoirs to diminazene, isometamidium and melarsoprol
11. Mechanisms of drug resistance in Leishmania
12. Induction of resistance to melarsene oxide cysteamine (Mel Cy) in Trypanosoma brucei brucei
13. Direct isolation in vitro of Trypanosoma brucei from man and its potential value for diagnosis of Gambian trypanosomiasis